Search

SpaMedica announces partnership with Macular Society

SpaMedica, one of the UK’s leading independent providers of NHS eye care services, is proud to announce a new partnership with the Macular Society, set to launch this month. The collaboration will help to fund ground-breaking research and vital support...

Green Charter inspires the Optical Community

Green Charter – the optical community’s clear pathway for a sustainable future – attracted great interest at 100% Optical, with businesses keen to learn more about specific guidance. Launched by Opticare Innovations, the commercial arm of the OSA, the five...

Landmark educational event for ophthalmology trainees hosted by Newmedica Suffolk

Ophthalmology trainees from the East of England were invited to attend a landmark surgical training event being hosted by Newmedica Suffolk in May 2025 where they were able to gain invaluable experience from national experts in the field of cataract...

Conference Report: OSI Dry Eye Masterclass & Symposium 2025: A first-hand experience

The Ocular Surface Insight (OSI) Dry Eye Masterclass & Symposium took place on the 27th and 28th of March 2025 at the Copthorne Tara Hotel in London, with the attendance of 186 delegates, bringing together experts, researchers, and clinicians from...

The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE

The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....

Standby for standards: Ophthalmic imaging

The Ophthalmic Imaging Associating (OIA) will propose and publish a volume of refined standards for Ophthalmic and Vision Science. These will be reviewed by the OIA membership at its annual conference in November 2025 and released thereafter. The OIA is...

Introducing BEAMS: A new national society for medical retina specialists

The specialty of medical retina is evolving. Initially, limited to pattern recognition and in later times, laser treatment, the past 20 years has seen an explosion of intravitreal therapies and a very rich pipeline resulting in sight-saving outcomes and hope...

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...

AI detects eye changes that lead to sight loss in young people

Use of Artificial Intelligence (AI) can accurately predict when young people with the sight- threatening eye condition kerataconus need treatment to stabilise the cornea and prevent loss of vision. Developed by researchers at Moorfields Eye Hospital and UCL Institute of...

UK Eye Genetics Group Annual Conference

by Chloe M. Stanton, UK-EGG Treasurer, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh Delegates including ophthalmic clinicians, clinical geneticists, genetic counsellors and research scientists travelled to Edinburgh from across the UK and Europe to attend...

UK Eye Genetics Group (UK-EGG) 2024

by Mohammed Aslam, FY 3 Doctor, Calderdale and Huddersfield NHS Foundation Trust, UK. Founded in 2002, the UK EGG provides a hub to share knowledge on inherited eye disease and train the next generation of clinicians and scientists. This year’s...

Charles Bonnet Syndrome Information Day

09:00 - 17:00 GMT